Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Human Organoids Market, by Region, 2018-2027 (USD Million)
1.2.2. Human Organoids Market, by Product, 2018-2027 (USD Million)
1.2.3. Human Organoids Market, by Application, 2018-2027 (USD Million)
1.2.4. Human Organoids Market, by End-User, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Organoids Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Processing Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Organoids Market Dynamics
3.1. Human Organoids Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Human Organoids Market Processing Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Human Organoids Market, by Product
5.1. Market Snapshot
5.2. Global Human Organoids Market by Type, Product - Potential Analysis
5.3. Global Human Organoids Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. Human Organoids Market, Sub Segment Analysis
5.4.1. Pancreas
5.4.2. Kidney
5.4.3. Lung
5.4.4. GIT
5.4.5. Liver Models
Chapter 6. Global Human Organoids Market, by Application
6.1. Market Snapshot
6.2. Global Human Organoids Market by Processing, Application - Potential Analysis
6.3. Global Human Organoids Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. Human Organoids Market, Sub Segment Analysis
6.4.1. Toxicity
6.4.2. Pathology
6.4.3. Personalized
6.4.4. Regenerative Medicine
Chapter 7. Global Human Organoids Market, by Use-End
7.1. Market Snapshot
7.2. Global Human Organoids Market by Processing, User-End - Potential Analysis
7.3. Global Human Organoids Market Estimates & Forecasts by User-End 2017-2027 (USD Million)
7.4. Human Organoids Market, Sub Segment Analysis
7.4.1. Customized
7.4.2. Ready-To-Use

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. BioIVT (US)
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Thermo Fisher Scientific (US)
8.2.3. ZenBio (US)
8.2.4. Corning (US)
8.2.5. Organovo (US)
8.2.6. Cyprid (France)
8.2.7. Biopredic International (France)
8.2.8. CELLINK (Sweden)
8.2.9. Emulate (US)
9.2.10Hrel Corporation (US)
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption